Xiaobo Wang

11.4k total citations · 3 hit papers
170 papers, 7.7k citations indexed

About

Xiaobo Wang is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Xiaobo Wang has authored 170 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 30 papers in Epidemiology and 19 papers in Oncology. Recurrent topics in Xiaobo Wang's work include Autophagy in Disease and Therapy (14 papers), Caveolin-1 and cellular processes (10 papers) and Sirtuins and Resveratrol in Medicine (9 papers). Xiaobo Wang is often cited by papers focused on Autophagy in Disease and Therapy (14 papers), Caveolin-1 and cellular processes (10 papers) and Sirtuins and Resveratrol in Medicine (9 papers). Xiaobo Wang collaborates with scholars based in China, United States and Belgium. Xiaobo Wang's co-authors include Michael P. Lisanti, Peter R. C. Gascoyne, Frederick F. Becker, Babak Razani, Ying Huang, Yuchen Ge, Chen Cui, Jun Yang, Philipp E. Scherer and Min Zhou and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaobo Wang

157 papers receiving 7.5k citations

Hit Papers

Caveolin-1 Null Mice Are ... 2001 2026 2009 2017 2001 2020 2021 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xiaobo Wang 3.3k 2.1k 1.3k 1.3k 787 170 7.7k
Jianjie Ma 4.5k 1.4× 853 0.4× 552 0.4× 854 0.7× 671 0.9× 209 8.8k
Nader Sheibani 4.8k 1.5× 752 0.4× 905 0.7× 835 0.7× 275 0.3× 342 10.4k
Xuejun Wang 6.8k 2.0× 2.3k 1.1× 676 0.5× 559 0.4× 1.6k 2.0× 360 11.2k
Daniel Figeys 6.6k 2.0× 562 0.3× 2.0k 1.6× 921 0.7× 281 0.4× 257 10.8k
Peng Li 6.3k 1.9× 684 0.3× 763 0.6× 1.4k 1.1× 536 0.7× 408 13.3k
P F Blackmore 5.2k 1.6× 813 0.4× 1.2k 0.9× 1.5k 1.2× 353 0.4× 157 10.9k
Takeshi Matsumura 3.2k 1.0× 554 0.3× 1.1k 0.9× 2.2k 1.8× 957 1.2× 150 10.5k
Siu Kwan Sze 9.0k 2.7× 909 0.4× 1.1k 0.9× 888 0.7× 690 0.9× 280 13.4k
Geert W. Schmid‐Schönbein 1.9k 0.6× 940 0.5× 866 0.7× 1.9k 1.5× 1.1k 1.4× 177 8.9k
Carlotta Giorgi 11.4k 3.4× 2.8k 1.4× 677 0.5× 1.9k 1.5× 570 0.7× 180 16.9k

Countries citing papers authored by Xiaobo Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaobo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Wang more than expected).

Fields of papers citing papers by Xiaobo Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Wang. The network helps show where Xiaobo Wang may publish in the future.

Co-authorship network of co-authors of Xiaobo Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobo Wang. A scholar is included among the top collaborators of Xiaobo Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobo Wang. Xiaobo Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Shuang, et al.. (2025). Understanding the Mechanism of Cardiotoxicity Induced by Nanomaterials: A Comprehensive Review. Small Science. 5(5). 2400498–2400498. 3 indexed citations
2.
Wang, Xiaobo, W. Wang, Asma Ejaz, et al.. (2025). Green synthesis of Colocasia esculenta-based silver nanoparticles: characterization and transdermal delivery for anti-inflammatory applications. Frontiers in Pharmacology. 16. 1611507–1611507.
3.
Ge, Yuchen, Bingxiang Zhao, Man Li, et al.. (2025). Experimental and network pharmacology certify itraconazole mitigates fluorouracil-induced intestinal damage by inhibiting mTOR-mediated intestinal senescence. Toxicology and Applied Pharmacology. 502. 117404–117404.
4.
Wang, Zhiwei, Yuchen Ge, Bingxiang Zhao, et al.. (2025). Vorinostat attenuates UVB-induced skin senescence by modulating NF-κB and mTOR signaling pathways. Scientific Reports. 15(1). 10905–10905. 4 indexed citations
5.
Wang, Xiaobo, et al.. (2024). An immunogenic cell death-related gene expression signature in predicting prognosis of pancreatic ductal adenocarcinoma. BMC Genomics. 25(1). 205–205. 2 indexed citations
6.
Wang, Xiaobo, et al.. (2024). Research progress of traditional Chinese medicine in the treatment of ischemic stroke by regulating mitochondrial dysfunction. Life Sciences. 357. 123045–123045. 9 indexed citations
7.
Wang, Zhiwei, Chen Cui, Zhenlin Liu, et al.. (2024). Network pharmacology and experimental verification revealing valnemulin alleviates DSS-induced ulcerative colitis by inhibiting intestinal senescence. International Immunopharmacology. 141. 112810–112810. 4 indexed citations
8.
Wang, Xiaobo, et al.. (2023). Relationship Between Infiltration of CD163+ TAMs, FoxP3+ Tregs, or CD66b+ TANs and Cell Differentiation in Colorectal Cancer Tissues. The Turkish Journal of Gastroenterology. 34(7). 747–752. 2 indexed citations
9.
Wang, Xiaobo, Jun Pu, Guixia Wang, et al.. (2023). Efficacy and safety analysis of angiotensin receptor neprilysin inhibition(ARNI)in patients with heart failure: a real-world retrospective study. BMC Cardiovascular Disorders. 23(1). 343–343. 2 indexed citations
10.
11.
Wang, Xiaobo, et al.. (2023). Comparison of Target Pocket Similarity and Progress into Research on Inhibitors of Picornavirus 3C Proteases. Chemistry & Biodiversity. 20(3). e202201100–e202201100. 1 indexed citations
12.
Chen, Zhongyu, et al.. (2023). Research Progress of Aging-related MicroRNAs. Current Stem Cell Research & Therapy. 19(3). 334–350. 17 indexed citations
13.
Xia, Jing, et al.. (2023). Peficitinib ameliorates 5-fluorouracil-induced intestinal damage by inhibiting aging, inflammatory factors and oxidative stress. International Immunopharmacology. 123. 110753–110753. 9 indexed citations
14.
Huang, Minghui, et al.. (2023). Microstructure Evolution and Mechanical Properties of Thick 2219 Aluminum Alloy Welded Joints by Electron-Beam Welding. Materials. 16(21). 7028–7028. 1 indexed citations
15.
Wang, Xiaobo, et al.. (2023). Virtual screening and molecular growth guide the design of inhibitors for the influenza virus drug-resistant mutant M2-V27A/S31N. Journal of Biomolecular Structure and Dynamics. 42(10). 5253–5267.
16.
Hu, Weifei, Xiaobo Wang, Zhiyu Jiang, et al.. (2021). A computational framework for coating fatigue analysis of wind turbine blades due to rain erosion. Renewable Energy. 170. 236–250. 27 indexed citations
18.
Xu, Xiao, Wanhong Xu, Wei Tang, et al.. (2016). AC0010, an Irreversible EGFR Inhibitor Selectively Targeting Mutated EGFR and Overcoming T790M-Induced Resistance in Animal Models and Lung Cancer Patients. Molecular Cancer Therapeutics. 15(11). 2586–2597. 69 indexed citations
19.
Xu, Jia, Jia Xu, Xiaobo Wang, et al.. (2001). Ion-channel assay technologies: quo vadis?. Drug Discovery Today. 6(24). 1278–1287. 128 indexed citations
20.
Huang, Ying, Jun Yang, Xiaobo Wang, Frederick F. Becker, & Peter R. C. Gascoyne. (1999). The Removal of Human Breast Cancer Cells from Hematopoietic CD34 + Stem Cells by Dielectrophoretic Field-Flow-Fractionation. Journal of Hematotherapy & Stem Cell Research. 8(5). 481–490. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026